Aug 25, 2025
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $0.95 to $9.50.
The split itself did not change the total investment value.
BriaCell Therapeutics Corp (TSX:BCT) operates in the Biotechnology industry.
BriaCell Therapeutics Corp company overviewBriaCell Therapeutics Corp's most recent stock split was on August 25, 2025. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
BriaCell Therapeutics Corp (TSX:BCT) has split its stock 4 times: a 4-for-13 reverse split on December 3, 2014, a 1-for-300 reverse split on January 3, 2020, a 1-for-15 reverse split on January 29, 2025, and a 1-for-10 reverse split on August 25, 2025.
BriaCell Therapeutics Corp has split its stock 4 times. This history records 4 reverse splits between December 3, 2014 and August 25, 2025.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In BriaCell Therapeutics Corp's 1-for-10 reverse split on August 25, 2025, every 10 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
BriaCell Therapeutics Corp has not announced a new split in our records. Its most recent split was on August 25, 2025, 1 year ago. Companies announce splits in advance, and any new TSX:BCT split will appear on this page.
Already premium?